ERDERA Clinical Trials Call & Joint Transnational Call
The first ERDERA Clinical Trials Call will be soon available: Clinical Trials Call funds controlled clinical research studies undertaken in humans to establish or confirm the safety and effectiveness of therapeutic interventions. These will benefit from ERDERA support for regulatory and methodological aspects.
ERDERA Joint Transnational Calls supports interdisciplinary research to address identified gaps. These calls foster cross-border collaboration and align with the strategic priorities of the rare disease community.
ERDERA Networking Support Scheme
A competitive funding instrument for networking events to share knowledge on rare diseases and rare cancers
Through this constantly open call, ERDERA supports the organisation of transnational networking events that promote knowledge sharing, research uptake and collaborations among clinicians, researchers, and patients/patient advocacy organizations (PAOs).
These events will strengthen new or expanding research networks on rare diseases and rare cancers in general and promote the inclusion of typically underrepresented countries (UCs) in European rare diseases and rare cancers networks in particular.
With funding of up to €30 000 per networking event, the scheme has been open since May 2025, offering a flexible framework for building the connections essential to meaningful knowledge sharing in rare disease and rare cancers research.
EP PerMed – Research Innovation and Technology Call for Proposals (RITC) 2026
The European Partnership for Personalised Medicine, EP PerMed (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129), is a platform for joint programming of national and European regional research and innovation supporting activities putting into action “The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (2023)”, SRIA for PM (2023), through dedicated research, development and innovation funding.
EP PerMed funding organisations agreed to launch a Research, Innovation and Technology Call (RITC) 2026, co-funded by the EU, to fund multinational, innovative research projects in personalised medicine, which should bring together teams from clinical/public health sector and enterprises as well as academic and non-for-profit teams. The RITC2026 will be conducted simultaneously by the participating funding organisations in their respective region/country and coordinated centrally by the Joint Call Secretariat (JCS), hosted by the French National Research Agency (ANR), France.
The call will be implemented in two stages, i.e. a pre- and a full-proposal phase. The available budget for this call is 13 Mio. € (approx.).
An information day introducing the RITC2026 to the research community will be organised on 28 October 2025. More details (including the registration) will follow soon.
| 12 January 2026 (14:00, CET) | Deadline for pre-proposal submission |
| 27 April 2026 (14:00, CEST) | Deadline for full-proposal submission |
IHI call 13
Call 13
The topics are currently under consultation. IHI call 13 is planned to be launched in summer 2026.
Calls of the European Commission
Please find here the links to calls of the European Commission you can apply to:
HORIZON EUROPE Work Programme
Funding opportunities under Horizon Europe are set out in multiannual work programmes. The Work programme addressing Health is the work programme – cluster 1. The aim of cluster 1 include improving and protecting the health and well-being of citizens of all ages by generating new knowledge, developing innovative solutions and integrating where relevant a gender perspective to prevent, diagnose, monitor, treat and cure diseases.